Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 744 clinical trials
None
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Radiation is a standard treatment option for patients with liver cancer. Unfortunately, the tumour grows after radiation in many patients and radiation can harm normal tissues. A new treatment

cancer
  • 0 views
  • 17 Sep, 2021
  • 1 location
None
Study of Pembrolizumab and Radiotherapy in Liver Cancer

This is a phase 2 study whose purpose is to assess the efficacy of the combination of pembrolizumab and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC) who have experienced disease progression after treatment with sorafenib.

sorafenib
hepatoma
metastasis
hepatitis
hepatitis b surface antigen
  • 23 views
  • 01 Dec, 2021
  • 1 location
None
Study of GNS561 in Patients With Liver Cancer

This is a first in human, open-label dose escalation study to investigate the safety, tolerability and pharmacokinetics of GNS561 in patients Primary and Secondary liver cancer

icca
hepatoma
antiviral drugs
platelet count
hepatitis
  • 41 views
  • 07 Aug, 2021
  • 5 locations
None
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer

Vast majority of patients with hepatocellular carcinoma (HCC) present with unresectable disease. In the last decade results of randomized trials and a subsequent metaanalyses established transarterial chemoembolization (TACE) or systemic chemotherapy (sorafenib) as standard of care. However, TACE alone is not a curative approach. The two year survival following TACE …

chemoembolization
sorafenib
cancer
stereotactic body radiation therapy
systemic chemotherapy
  • 42 views
  • 24 Jan, 2021
  • 2 locations
None
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

This is a phase 2 study that will assess the investigational drug, cabozantinib, in patients with liver cancer (specifically hepatocellular carcinoma) and who had received a liver transplant as

sorafenib
systemic therapy
liver transplant
tyrosine
cabozantinib
  • 0 views
  • 18 Apr, 2021
  • 1 location
None
Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

To explore the utility of personalized 3D printed liver models in planning and navigating laparoscopic resections.

liver tumor
hepatectomy
hepatoma
  • 10 views
  • 19 Feb, 2021
  • 2 locations
None
Combination of TATE and PD-1 Inhibitor in Liver Cancer

This is a single center, open-label phase IIA study that investigates the preliminary efficacy of Trans-arterial Tirapazamine Embolization (TATE) treatment of liver cancer followed by a PD-1

lung carcinoma
pembrolizumab
sorafenib
measurable disease
systemic chemotherapy
  • 28 views
  • 29 Jan, 2021
  • 1 location
None
ALPPS Combined With Tislelizumab in Liver Malignancy

Study design: Prospective, single-center, phase IIa clinical trial; Primary endpoint: Recurrence free survival; Secondary endpoints: Safety, overall survival; Main characteristics of patients: Liver malignancy, required (extended) hemihepatectomy, insufficient liver reserve; Study approaches: The experimental group is treated with ALPPS combined with Tislelizumab, and the control group was treated with ALPPS; …

  • 0 views
  • 19 Aug, 2021
  • 1 location
None
Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery

"Indocyanine Green (ICG) is a dye used as an indicator of hepatic function considering its capacity to be eliminated only by the bile. Thus, ICG tend to remain in liver tumors. The

liver surgery
hepatoma
indocyanine green
  • 1 views
  • 23 Jan, 2021
  • 1 location
None
Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a new surgical procedure that induces rapid liver regeneration in patients with small liver remnant planning for major liver resection. It is a two-staged operation with stage I including portal vein ligation and splitting the right liver away …

  • 0 views
  • 10 May, 2021
  • 1 location